Protalix Biotherapeutics Inc (NYSE American:PLX)

0.445
Delayed Data
As of Nov 16
 -0.0029 / -0.65%
Today’s Change
0.38
Today|||52-Week Range
0.83
-32.70%
Year-to-Date

Today’s Trading

Previous close0.45
Today’s open0.47
Day’s range0.43 - 0.47
Volume159,163
Average volume (3 months)769,344
Market cap$66.5M
Data as of 3:59pm ET, 11/16/2018

Growth & Valuation

Earnings growth (last year)-124.45%
Earnings growth (this year)+36.11%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+109.17%
P/E ratioNM
Price/Sales4.50
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VTGNVistaGen Therapeutic...-0.06-3.24%
ONSOncobiologics Inc+0.02+2.83%
LPTXLeap Therapeutics In...+0.30+8.57%
KMPHKemPharm Inc+0.19+8.09%
Data as of 4:00pm ET, 11/16/2018

Financials

Next reporting dateMarch 14, 2019
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$19.2M
Annual profit (last year)-$85.3M
Net profit margin-443.18%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Senior Vice President-
Operations
Yaron Naos
Corporate headquarters
Carmiel, Hazafon

Forecasts